More than the heart: Hepatic, renal, and cardiac dysfunction in adult Fontan patients
Ryan Byrne(Monroe Carell Jr. Children's Hospital), Benjamin P. Frischhertz(Vanderbilt University Medical Center), Larry W. Markham(Riley Hospital for Children), Roman Perri(Vanderbilt University Medical Center), Angela Weingarten(Vanderbilt University Medical Center), Daniel E. Clark(Stanford University), Andrew Scanga(Vanderbilt University Medical Center), Jonathan N. Menachem(Vanderbilt University Medical Center), Shi Huang(Vanderbilt University Medical Center)
Cited by 20
Related Papers
Results of the FUEL Trial
|Circulation|2019|160
Steroid Therapy and Cardiac Function in Duchenne Muscular Dystrophy
|Pediatric Cardiology|2005|125
Epigenetic Regulation of Protein-Coding and MicroRNA Genes by the Gfi1-Interacting Tumor Suppressor PRDM5
|Molecular and Cellular Biology|2007|93
Abnormalities of Diastolic Function Precede Dilated Cardiomyopathy Associated with Duchenne Muscular Dystrophy
|Journal of the American Society of Echocardiography|2006|89
Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation
|Journal of the American College of Cardiology|2023|79